EUVIMEDEUVIMED entdecken
Kohortenstudie

Risk of recurrence in patients with provoked venous thromboembolism: a prospective cohort study

Sabine Eichinger iD, Lisbeth Eischer, Alexandra Kaider, Georg Heinze, Peter Quehenberger, Paul A Kyrle

Blood · 12.11.2026 · 148 (20) · 2489-2496

DOI: 10.1182/blood.2026034774 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Blood, erschienen am 12.11.2026. Verfasst von Sabine Eichinger und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Hemostasis, Department of Medicine I, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Venous Thromboembolism. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Venous thromboembolism (VTE) provoked by transient risk factors is generally considered low risk, supporting short-term anticoagulation. However, this paradigm is based on heterogeneous definitions of provoking factors. In this prospective cohort study, we evaluated recurrence risk using the International Society on Thrombosis and Haemostasis classification of major and minor transient risk factors. Patients with symptomatic deep vein thrombosis and/or pulmonary embolism who completed ≥3 months of anticoagulation were followed after treatment discontinuation. Patients with cancer, major thrombophilia, pregnancy-associated VTE, or indication for extended anticoagulation were excluded. The primary outcome was symptomatic recurrent VTE. Cumulative incidence was estimated by Kaplan-Meier analysis. The study was terminated early due to unexpectedly high recurrence risk among patients with major provoking factors. Between 2019 and 2025, 242 patients were followed for a median of 23.9 months; 72 had major and 170 had minor transient risk factors. Recurrent VTE occurred in 13 patients with major and 7 with minor risk factors. At 24 months, recurrence risk was 9.5% (95% confidence interval [CI], 6.0-14.0) overall and 19.7% (11.0-30.2) after major and 5.0% (2.2-9.5) after minor risk factors. No recurrence occurred in 81 women with hormone-associated VTE; after their exclusion, the recurrence risk among patients with other minor risk factors increased to 9.1% (95% CI, 4.0-17.0). Recurrence after provoked VTE is not uniformly low and varies substantially by the type of transient risk factor. These findings challenge current treatment paradigms and support individualized decisions regarding anticoagulation duration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Venous ThromboembolismHumansFemaleRecurrenceProspective StudiesRisk FactorsMiddle AgedMaleAnticoagulantsAdultAgedPulmonary EmbolismVenous Thrombosis

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Division of Hematology and Hemostasis, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Karl Landsteiner Institute of Thrombosis Research, Vienna, Austria.
  • Institute of Clinical Biometrics, Center for Medical Data Science, Medical University of Vienna, Vienna, Austria.
  • Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.

ORCID-Profile: Sabine Eichinger

Zitieren

APA

Eichinger, S., Eischer, L., Kaider, A., Heinze, G., Quehenberger, P., & Kyrle, P. A. (2026). Risk of recurrence in patients with provoked venous thromboembolism: a prospective cohort study. Blood, 148(20), 2489-2496. https://doi.org/10.1182/blood.2026034774

Vancouver

Eichinger S, Eischer L, Kaider A, Heinze G, Quehenberger P, Kyrle PA. Risk of recurrence in patients with provoked venous thromboembolism: a prospective cohort study. Blood. 2026;148(20):2489-2496. doi:10.1182/blood.2026034774

BibTeX
@article{Eichinger2026,
  author = {Eichinger, Sabine and Eischer, Lisbeth and Kaider, Alexandra and Heinze, Georg and Quehenberger, Peter and Kyrle, Paul A},
  title = {Risk of recurrence in patients with provoked venous thromboembolism: a prospective cohort study},
  journal = {Blood},
  year = {2026},
  volume = {148},
  number = {20},
  pages = {2489--2496},
  doi = {10.1182/blood.2026034774}
}
Kostenlos starten →